Tome Biosciences Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tome Biosciences's estimated annual revenue is currently $26.8M per year.(i)

Employee Data

    Tome Biosciences's People

    NameTitleEmail/Phone
    1
    SVP FinanceReveal Email/Phone
    2
    Senior Director, Chemistry & Chemical Hygiene OfficerReveal Email/Phone
    3
    VP Clinical StrategyReveal Email/Phone
    4
    Director & Founding Head Platform InnovationsReveal Email/Phone
    5
    Associate DirectorReveal Email/Phone
    6
    Associate DirectorReveal Email/Phone
    7
    Senior DirectorReveal Email/Phone
    8
    Director, Delivery & Process SciencesReveal Email/Phone
    9
    Associate DirectorReveal Email/Phone
    10
    DirectorReveal Email/Phone
    Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
    #1
    $5.2M67-45%$107.3MN/A
    #2
    $0.3M20%N/AN/A
    #3
    $5.1M336%N/AN/A
    #4
    $11.9M77-37%$312.8MN/A
    #5
    $0.9M60%N/AN/A
    #6
    $235M300-5%$340.9MN/A
    #7
    $45.9M237-7%$7.6MN/A
    #8
    $3.9M5035%N/AN/A
    #9
    N/A1110%N/AN/A
    #10
    $5.4M353%N/AN/A
    Add Company

    What Is Tome Biosciences?

    Tome Biosciences is the programmable gene insertion company. Using CRISPR, our technologies allow us to insert any genetic sequence of any size at any location into any genome. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and genome engineering.

    keywords:N/A

    N/A

    Total Funding

    N/A

    Number of Employees

    $26.8M

    Revenue (est)

    N/A

    Employee Growth %

    N/A

    Valuation

    N/A

    Accelerator